doi: 10.1002/art.23721.
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
Collaborators,
Affiliations
- PMID: 18512708
- DOI: 10.1002/art.23721
Item in Clipboard
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
Arthritis Rheum.
.
Free article
No abstract available
Comment in
-
The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road.Arthritis Rheum. 2008 Jun 15;59(6):757-9. doi: 10.1002/art.23723. Arthritis Rheum. 2008. PMID: 18512712 No abstract available.
Similar articles
-
The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road.Arthritis Rheum. 2008 Jun 15;59(6):757-9. doi: 10.1002/art.23723. Arthritis Rheum. 2008. PMID: 18512712 No abstract available.
-
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.Arthritis Care Res (Hoboken). 2012 May;64(5):625-39. doi: 10.1002/acr.21641. Arthritis Care Res (Hoboken). 2012. PMID: 22473917 Free PMC article. Review. No abstract available.
-
Oral glucocorticoids should be included in any recommendation for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: comment on the article by Singh et al.Arthritis Care Res (Hoboken). 2012 Oct;64(10):1622-3; author reply 1623-4. doi: 10.1002/acr.21809. Arthritis Care Res (Hoboken). 2012. PMID: 23024030 No abstract available.
-
Level of the indication of biologic agents in the 2012 American College of Rheumatology recommendations for the treatment of rheumatoid arthritis: comment on the article by Singh et al.Arthritis Care Res (Hoboken). 2013 May;65(5):832. doi: 10.1002/acr.21873. Arthritis Care Res (Hoboken). 2013. PMID: 23097263 No abstract available.
-
Adherence to biologic DMARD therapies in rheumatoid arthritis.Expert Opin Biol Ther. 2010 Sep;10(9):1367-78. doi: 10.1517/14712598.2010.510508. Expert Opin Biol Ther. 2010. PMID: 20681888 Review.
Cited by
-
Sulfasalazine-Induced Agranulocytosis: A Case Series and Review of Literature.Mediterr J Rheumatol. 2024 Sep 30;35(3):479-483. doi: 10.31138/mjr.010124.sia. eCollection 2024 Sep. Mediterr J Rheumatol. 2024. PMID: 39463872 Free PMC article.
-
Diagnostic Complexities and Management of Gouty Arthritis With Suspected Seronegative Rheumatoid Arthritis and Malignancy in an Elderly Male.Cureus. 2024 Sep 7;16(9):e68860. doi: 10.7759/cureus.68860. eCollection 2024 Sep. Cureus. 2024. PMID: 39376825 Free PMC article.
-
On difficulties to define prognostic factors for clinical practice in rheumatoid arthritis.RMD Open. 2024 Sep 28;10(3):e004472. doi: 10.1136/rmdopen-2024-004472. RMD Open. 2024. PMID: 39343442 Free PMC article. Review.
-
Patient Characteristics and Outcomes Associated with Sentinel Protection Device Use in Patients with Aortic Valve Disease Undergoing TAVR in a "Real-World" Setting.Rev Cardiovasc Med. 2024 Jan 4;25(1):3. doi: 10.31083/j.rcm2501003. eCollection 2024 Jan. Rev Cardiovasc Med. 2024. PMID: 39077657 Free PMC article.
-
Impact of MTHFR gene polymorphism on the outcome of methotrexate treatment in a sample of Iraqi rheumatoid arthritis patients.Sci Rep. 2024 Jul 2;14(1):15119. doi: 10.1038/s41598-024-65199-7. Sci Rep. 2024. PMID: 38956106 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
